Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Jun-ichi Sudo"'
Autor:
Jun-ichi Sudo, Fumiji Miyasaka, Kimio Higashiyama, Takashi Meguro, Kozo Takayama, Hiroaki Iwase, Katsuhiko Kakuno
Publikováno v:
Drug Development and Industrial Pharmacy. 28:59-65
To increase delivery of L-dopa in its transdermal absorption, a new lipophilic derivative of L-dopa, L-dopa-butylester, was synthesized. An in-vitro study employing two-chamber diffusion cells, in which the excised rat abdominal skin was mounted, rev
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 744:19-23
An HPLC assay for determination of ATPase activity was developed and validated. After stopping the enzyme reaction of the enzyme source (rat renal cortical basolateral membranes) with ATP, products derived from ATP were analyzed by two methods; HPLC
Autor:
Jun-ichi Sudo, Jun Terui, Tsuneji Nagai, Hiroaki Iwase, Kozo Takayama, Takiko Watanabe, Katsuhiko Kakuno
Publikováno v:
Drug Development and Industrial Pharmacy. 26:755-759
To maintain the stability of L-dopa in hydrogel, a new system composed of two separate layers of L-dopa and hydrogel was developed. L-Dopa sheets were made by immersing L-dopa solution into wiper sheets and by lyophilizing them. Examination for stabi
Autor:
Kyoko Kon, Motoki Yonekawa, Kazutaka Kukita, Toshio Higa, Jun-ichi Sudo, Akio Kawamura, Jun Terui, Tadamasa Kon
Publikováno v:
Clinical and Experimental Nephrology. 3:23-28
Background. Desferrioxamine (DFO) a chelating agent, is used to treat metal toxicity caused by iron and aluminum in patients on hemodialysis. We hypothesized that DFO could also be used to treat cadrium-induced nephropathy. Animal experiments were th
Autor:
Jun-ichi Sudo, Kozo Takayama, Jun Terui, Momoko Soyama, Katsuhiko Kakuno, Tsuneji Nagai, Hiroaki Iwase
Publikováno v:
European Journal of Pharmaceutical Sciences. 7:67-71
To improve compliance in administration of l-dopa, transdermal absorption of the agent was investigated in rats in vitro employing two-chamber diffusion cells in which the excised rat abdominal skin was mounted, and in vivo using an alcoholic hydroge
Publikováno v:
European Journal of Pharmacology: Environmental Toxicology and Pharmacology. 270:229-235
To explore the kinetics of Cd2+ in the body, rats received a single intravenous injection of CdCl2 or Cd-saturated metallothionein-II at 0.3 mg Cd/kg body weight. Cd2+ in the two agents was biexponentially eliminated from plasma: rapidly in the first
Autor:
Jun-ichi Sudo, Taiji Hayashi
Publikováno v:
The Journal of Toxicological Sciences. 17:31-39
To comparably investigate hemotoxic potentials of CdCl2, cadmium-saturated metallothioneins-I (Cd-MT-I) and -II (Cd-MT-II), rats received single intravenous injections of one of those dissolved in saline with equivalent concentrations of Cd (0, 0.1,
Autor:
Yoshihiro SUZUKI, Jun-ichi SUDO
Publikováno v:
Japanese Journal of Pharmacology. 52:233-244
Autor:
Nobuhiko Yamazaki, Tomizo Okuyama, Jun-ichi Sudo, Tsuneyoshi Tanabe, Tohru Kaku, Takashi Kubota, Yoshio Monma
Publikováno v:
The Journal of Toxicological Sciences. 15:1-13
Employing propranolol as a non-selective beta-blocker, atenolol, acebutolol and metoprolol as selective beta 1-blockers, butoxamine as a selective beta 2-blocker, labetalol as an alpha- and beta-blocker, and phentolamine as an alpha-blocker, we compa
Publikováno v:
Biological and Pharmaceutical Bulletin. 17:871-873
To explore the mechanism responsible for puromycin aminonucleoside induced-nephrotoxicity, metal content was preliminarily investigated in the kidneys of rats that had received a single subcutaneous injection of the agent (80 mg/kg body weight). In t